Company News

Atlas Antibodies Launches AtlasPlex IHC Kit: Multiplexing Made Simple

Bengt Thorsson and Johan Rockberg to join Atlas Antibodies’ Board of Directors

In the media - Stronger Together: A Conversation with Atlas Antibodies CEO Ingela Hofverberg

In a recent interview with Stockholm Science City Foundation, Atlas Antibodies CEO Ingela Hofverberg reflects on a year marked by growth, innovation, and a strategic move to the heart of Sweden’s most vibrant life science district — Hagastaden.

Dan Pitulia Appointed as Group CEO of the Atlas Antibodies Group

Dan Pitulia Appointed as Group CEO of the Atlas Antibodies Group

Atlas Antibodies to Exhibit at Cell Bio 2024 in San Diego, Highlighting Innovative MolBoolean™ Technology

Atlas Antibodies to Showcase Innovation at Society for Neuroscience Annual Meeting 2024 in Chicago

Atlas Antibodies Presents Pan-Cancer Markers and New Product MolBoolean at EACR 2024

Atlas Antibodies Unveils Revolutionary Molecular Tool, MolBoolean™

Atlas Antibodies is going green!

Ingela Hofverberg appointed as CEO of Atlas Antibodies BU

The Human Protein Atlas (HPA) selected as a Global Core Biodata Resource

Atlas Antibodies acquires HistoCyte Laboratories Ltd.

Atlas Antibodies acquires evitria

Atlas Antibodies has new Chair of the Board Åsa Riisberg

Dr. Stefan Schmidt new CEO of evitria

Gavin Wood and Christian Eberle join Atlas Antibodies’ Board of Directors